2651 - 2660 of 8571 Results
Title
Year
-
RESTRICTEDTitle: Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disordersJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 147Issue #:Start Page: 104343End Page: 104343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2019.104343Best OA location URL: https://flore.unifi.it/bitstream/2158/1175329/1/2019%20Harnessing%20ion%20channel.pdfCitation Count: 7
-
RESTRICTEDTitle: Striatal cholinergic interneurons and Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 10Start Page: 1148End Page: 1158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13638Best OA location URL: https://europepmc.org/articles/pmc6074051?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Blood-based biomarkers for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: S99End Page: S103Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(13)70025-7Best OA location URL: https://europepmc.org/articles/pmc4070332?pdf=renderCitation Count: 123
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
-
RESTRICTEDTitle: Oxidized DJ-1 as a possible biomarker of Parkinson’s diseaseJournal Name: Journal of Clinical Biochemistry and NutritionPublisher: The Society for Free Radical Research JapanVol: 54Issue #: 3Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3164/jcbn.13-108Best OA location URL: https://www.jstage.jst.go.jp/article/jcbn/54/3/54_13-108/_pdfCitation Count: 61
-
RESTRICTEDTitle: Leucine‐rich repeat kinase 2 and Parkinson's diseaseJournal Name: PROTEOMICSPublisher: WileyVol: 17Issue #: 1-2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmic.201600092Citation Count: 23
- Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein2016RESTRICTEDTitle: Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synucleinJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 42Issue #: 1Start Page: 51End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12299Citation Count: 66
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21
- Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment2011RESTRICTEDTitle: Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive ImpairmentJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 5Start Page: 455End Page: 463Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-011-0212-0Best OA location URL: https://europepmc.org/articles/pmc3213691?pdf=renderCitation Count: 10
- Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science2020RESTRICTEDTitle: Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 4Issue #: Suppl. 1Start Page: 28End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000512500Best OA location URL: https://www.karger.com/Article/Pdf/512500Citation Count: 43